CNDR - Canadian Neuromuscular Disease Registry
Canadians working together in the fight against neuromuscular disease

Home > ABOUT CNDR > CNDR Advisory Committee
CNDR Advisory Committee  

The CNDR Advisory Committee (CNDRAC) is a group of doctors and scientists from all over Canada. These experts provide scientific and medical consultation and recommendations to the CNDR National Principal Investigator. The CNDRAC also reviews research proposals and requests for release of data sent to the CNDR and oversees the disease-specific working groups, dataset function, and scientific integrity. All members of the CNDRAC are volunteers.

Lawrence Korngut

CNDR National Principal Investigator: Lawrence Korngut MD FRCPC (Neurology) CSCN(EMG)

Dr. Korngut is a clinical assistant professor in the Department of Clinical Neurosciences at the University of Calgary. He is a neuromuscular neurologist at the adult Neuromuscular Clinic in Calgary, Alberta and is the Associate Director of the Calgary Motor Neuron Disease/ALS Clinic. His research interests include registry development and use for clinical research, translational clinical trials of novel therapeutic agents for neuromuscular diseases, and neuromuscular disease epidemiology in Canada.

Craig Campbell

CNDR Pediatric Disease Expert: Craig Campbell MD, MSc FRCPC (Neurology) CSCN(EMG)

Dr. Campbell is the medical director of the Pediatric Neuromuscular Clinic and Pediatric Neurophysiology Laboratory at the Children's Hospital in London, Ontario. Dr. Campbell is also an associate professor of Pediatrics, Clinical Neurology, and Epidemiology and Biostatistics at the University of Western Ontario. As the director of the William Singeris National Centre for Myotonic Dystrophy Research, Dr. Campbell has an active neuromuscular research program with a focus on understanding the clinical aspects of Childhood and Congenital Myotonic Dystrophy, Duchenne Muscular Dystrophy, and Spinal Muscular Atrophy. His interests focus on clinical outcomes research and understanding these neuromuscular diseases at a population level.

Timothy Benstead

CNDR Adult Disease Expert: Timothy Benstead, MD, FRCPC

Dr. Benstead is a neuromuscular specialist at Dalhousie University. He is a professor in the Division of Neurology and has held several administrative positions locally and nationally in clinical care, research, and medical education. He has research interests in acquired and inherited peripheral neuropathies, motor neuron disease and clinical electrophysiology. His clinical roles include the care of patients in the Neuromuscular and ALS clinics at the Capital District Health Authority in Halifax.

CNDR Duchenne Muscular Dystrophy Disease Working Group Lead: Anna McCormick, MD, FRCPC

Dr. McCormick is the Medical Director of the Pediatric Rehabilitation Service Unit at the Children's Hospital of Eastern Ontario. She is also a Rehabilitation consultant at the Ottawa Children's Treatment Center and the Ottawa Rehabilitation Center. She is one of few physicians in Canada who specializes in both pediatrics and physical medicine and rehabilitation. Dr. McCormick is an Associate Professor at the University of Ottawa. Her research interests are diverse and have included evaluation of the use of Botulinum Toxin A in adults with cerebral palsy, transition of young adults to adult care, and the use of virtual reality systems to facilitate physical rehabilitation.